CONCLUSIONS
Two 25-μg doses of the mRNA-1273 vaccine were found to be safe in children 6 months to 5 years of age and elicited immune responses that were NONINFERIOR (my emphasis) to those in young adults. (Funded by the Biomedical Advanced Research and Development Authority and National Institute of Allergy and Infectious Diseases; KidCOVE ClinicalTrials.gov number, NCT04796896.)
-------------------
Now it's your turn to provide data that refutes the NEJM findings...if you can't come up with it, a simple apology will be sufficient.
Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2209367